AstraZeneca has announced plans to invest $50 billion in the U.S. by 2030 amid concerns over tariffs
Browsing: AstraZeneca
Beijing assures US and other foreign business leaders that it will continue to open its market to investments and collaborations
The transaction is expected to close in the second quarter of 2025, which will include AstraZeneca will buying all outstanding equity in EsoBiotec on a cash and debt-free basis